Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial (Q44991597)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial |
scientific article |
Statements
1 reference
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial (English)
1 reference
Rodryg Ramlau
1 reference
Charles Butts
1 reference
Mark A Socinski
1 reference
Paul L Mitchell
1 reference
Nick Thatcher
1 reference
Libor Havel
1 reference
Tudor-Eliade Ciuleanu
1 reference
Lionel Bosquée
1 reference
José Manuel Trigo
1 reference
Alexander Spira
1 reference
Lise Tremblay
1 reference
Jan Nyman
1 reference
Gun Wickart-Johansson
1 reference
Peter Ellis
1 reference
Oleg Gladkov
1 reference
José Rodrigues Pereira
1 reference
Wilfried Ernst Erich Eberhardt
1 reference
Christoph Helwig
1 reference
Andreas Schröder
1 reference
Frances A Shepherd
1 reference
START trial team
1 reference
9 December 2013
1 reference
1 reference
15
1 reference
1
1 reference
59-68
1 reference
Identifiers
1 reference
1 reference